Novocure Net Worth

Novocure Net Worth Analysis

Know Novocure's Top Institutional Investors

Note, although Novocure's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Novocure's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.43 B.

Project Novocure's profitablity

The company has Profit Margin (PM) of (0.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.21.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Novocure's management efficiency

Novocure has return on total asset (ROA) of (0.0793) % which means that it has lost $0.0793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3971) %, meaning that it created substantial loss on money invested by shareholders. Novocure's management efficiency ratios could be used to measure how well Novocure manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/18/2025, Return On Tangible Assets is likely to drop to -0.17. In addition to that, Return On Capital Employed is likely to drop to -0.23. At this time, Novocure's Total Assets are relatively stable compared to the past year. As of 02/18/2025, Non Current Assets Total is likely to grow to about 134.9 M, while Other Current Assets are likely to drop slightly above 6.6 M.

Novocure Corporate Filings

Novocure time-series forecasting models is one of many Novocure's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novocure's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Novocure Earnings per Share Projection vs Actual

Novocure Corporate Management

Additional Tools for Novocure Stock Analysis